Abbott India Limited

NSE: ABBOTINDIA · Pharmaceuticals · sector

₹25,225.00NSE close 2026-10-26

Key numbers

Market cap₹53,603 cr

Price₹25,225.00

52w high / low₹30,655 / ₹25,135

P/E33.2xSector median 27.9x

P/B11.2xSector median 2.9x

Book value₹2,246.7

Dividend yield1.88%Sector median 0.48%

ROE35.9%Sector median 11.7%

ROCE45.7%Sector median 12.3%

OPM28.1%Sector median 14.0%

Debt / equity0.00xSector median 0.16x

EV/EBITDA26.1xSector median 18.6x

Interest cover87.1x

Current ratio2.55x

Sales growth 3y+9.0%Sector median +9.6%

Profit growth 3y+17.8%Sector median +13.3%

PEG1.86x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹2,255 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 87.1x in the last 12 months.
Other income was 18% of net profit in the last 12 months.
Dividend paid in 5 of the last 5 financial years.
Price ₹25,225.00 on 2026-10-26: -17.7% from the 52-week high, +0.4% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹34,710.00 · low ₹25,180.00

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1,605	1,738	1,757	1,724	1,710	1,814
EBITDA	429	446	502	463	481	522
OPM %	26.7%	25.6%	28.6%	26.9%	28.1%	28.8%
Other income	76	73	70	70	76	75
Net profit	367	366	415	376	395	429
EPS (₹)	172.72	172.17	195.42	176.92	185.85	201.66
Revenue YoY					+6.5%	+4.3%
Profit YoY					+7.6%	+17.1%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	4,919	5,349	5,849	6,409	6,929	7,004
EBITDA	1,088	1,206	1,453	1,695	1,892	1,969
Net profit	799	949	1,201	1,414	1,552	1,615
EPS (₹)	375.86	446.78	565.28	665.62	730.36	759.85
Revenue growth		+8.7%	+9.4%	+9.6%	+8.1%	–
Profit growth		+18.9%	+26.5%	+17.8%	+9.7%	–
Dividend / share (₹)	120.00	145.00	180.00	410.00	475.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+9.0%	–	–
Net profit	+17.8%	–	–
EPS	+17.8%	–	–
Share price	–	-6.2% (2y)	-15.1%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	4,233	4,774
Borrowings	0	0
Cash & equivalents	1,628	2,255
Total assets	5,917	6,502
Fixed assets	330	328
Capital work in progress	18	6
Investments	0	0
Receivables	380	362
Inventory	882	947
Payables	1,058	1,107

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	1,012	1,319
Cash from investing	182	-371
Cash from financing	-925	-1,066
Capex	53	41
Free cash flow	959	1,278

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	33.4%	32.5%
ROCE %	44.8%	44.1%
Debtor days	22	19
Inventory days	92	94
Payable days	110	109
Cash conversion cycle (days)	4	4
Working capital days	190	121

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
ABBOTINDIA	₹53,603 cr	33.2x	11.2x	35.9%	45.7%	28.1%	+9.0%	1.88%

All 185 companies in Pharmaceuticals →

Dividends & corporate actions

Ex-date	Action	Detail
2026-07-24	Dividend	Dividend - Rs 525 Per Share & Special Dividend Rs 131 Per Share
2025-07-25	Dividend	Dividend - Rs 475 Per Share
2024-07-19	Dividend	Dividend - Rs 410 Per Share
2023-07-21	Dividend	Dividend - Rs 180 Per Share/ Special Dividend Rs 145 Per Share
2022-08-02	Dividend	Annual General Meeting/Dividend - Rs 145 Per Share/Special Dividend- 130 Per Share
2021-07-19	Dividend	Annual General Meeting/Dividend - Rs 120 Per Share Special Dividend 155 Per Share
2020-08-28	Dividend	Annual General Meeting/Dividend - Rs 107 Per Share And Special Dividend - Rs 143 Per Share
2019-08-13	Dividend	Annual General Meeting/ Final Dividend - Rs 50 Per Share/ Special Dividend - Rs 15 Per Share
2018-07-10	Dividend	Annual General Meeting / Final Dividend- Rs 50 Per Share / Special Dividend- Rs 5 Per Share
2017-07-10	Dividend	Annual General Meeting/Dividend Rs 40/- Per Share
2016-07-08	Other	Annual General Meeting/Divided - Rs 35/- Per Share
2015-07-22	Dividend	Annual General Meeting/Dividend - Rs 31/- Per Share
2014-07-23	Dividend	Annual General Meeting / Final Dividend - Rs 23/- Per Share
2013-04-16	Dividend	Annual General Meeting And Dividend Rs.17 Per Share
2012-05-04	Dividend	Annual General Meeting And Dividend Rs.17/- Per Share
2011-04-19	Dividend	Annual General Meeting / Final Dividend - Rs.17/- Per Share
2010-03-03	Other	Agm/Div-Rs.17/- Per Share

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	ABBOTINDIA
BSE code	500488
ISIN	INE358A01014
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = NSE close 2026-10-26.